An Act Concerning The Return Of Health Care Provider Payments, Establishing A Working Group To Study Pharmacist Compensation For Administering Certain Services, Revising The Definition Of Clinical Peer And Concerning The Connecticut Unfair Insurance Practices Act.
HB 7039 makes several changes to Connecticut insurance and health care payment law. First, it shortens from 18 months to 12 months the period during which a contracting health organization may cancel, deny, or demand repayment of an authorized covered service payment because of administrative or eligibility error, while preserving exceptions for fraud, incorrect billing, duplicate payment, government program payment, and certain coordination-of-benefits situations. It also requires advance notice, disclosure of the basis for any repayment demand, an appeal process with electronic appeal options, and stays repayment demands while an appeal is pending.
The bill also creates a working group to study compensation for pharmacists who provide certain services such as vaccine administration, HIV and influenza testing, and prescribing contraceptive devices or products. The working group must include legislative leaders, state regulators, pharmacists from both independent and chain pharmacies, PBM representatives, insurers, and pharmaceutical industry representatives, and it must report recommendations by February 1, 2026.
In addition, the bill revises the definition of “clinical peer” for utilization review and mental health/substance use disorder reviews, specifying the qualifications needed for physicians, psychologists, and other health care professionals. It also expands the Connecticut Unfair Insurance Practices Act by adding new prohibited practices related to provider network participation, notice and explanation of network-status decisions, communication with designated representatives or contracting agents, adherence to written agreements or fee schedules, and violations of the revised provider-notification statute.
The bill’s impact on state law is broad but targeted: it strengthens provider protections in payment recoupment disputes, adds new insurer conduct standards, and clarifies review standards for behavioral health and other clinical determinations. It also creates a formal process to study pharmacist reimbursement issues without immediately mandating a compensation change. The affected parties include health insurers, health care providers, pharmacists, pharmacy benefits managers, and other entities that contract with providers or manage provider networks.
The general sentiment appears favorable, as reflected by the INS Joint Favorable Substitute vote of 10-3. The bill seems designed to address provider concerns about delayed recoupment demands, network-status communication, and insurer conduct, while also acknowledging ongoing policy questions about pharmacist compensation. The main points of contention likely center on insurer authority and administrative flexibility versus provider protections, especially the shorter recoupment window, the expanded unfair-practices provisions, and the new requirements for network participation decisions and notices.
HB 7039 amends several sections of the Connecticut General Statutes governing health insurance, provider payment recoupment, utilization review, and unfair insurance practices. It shortens the recoupment lookback period in section 38a-479b, expands notice and appeal rights for providers, revises the clinical peer definition in section 38a-591a, adds new unfair-practice prohibitions in section 38a-816, and strengthens provider-notification requirements in section 38a-472f. It also creates a temporary working group to study pharmacist compensation for certain clinical services.
The bill received a favorable committee recommendation, passing the Insurance and Real Estate Committee as a Joint Favorable Substitute by a 10-3 vote. That suggests overall support for the bill’s provider-protection and transparency measures, though the split vote indicates some reservations. The available record does not include detailed transcript debate, but the structure of the bill indicates a policy direction generally favorable to health care providers and pharmacists, with added oversight of insurer and network practices.
The likely areas of disagreement are the provisions that limit insurer recoupment and expand liability under the Connecticut Unfair Insurance Practices Act. Insurers and other payors may object to the shorter 12-month repayment window, the stay of repayment demands during appeals, and the requirement that network-status decisions be made in good faith and not based solely on financial impact. Providers, by contrast, are likely to support these protections, along with clearer notice obligations and the ability to challenge repayment demands. The pharmacist compensation study appears less contentious because it only creates a working group rather than changing payment rules immediately, but it still implicates pharmacy chains, independent pharmacies, PBMs, insurers, and pharmaceutical companies.